Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ARC PHARMA
Vancouver, British Columbia, Canadaarcpharma.co.uk ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
ARC Pharmaceuticals develops medical products targeting proliferative diseases, with an initial focus on preventing surgical adhesion disease—a major complication following surgery. The company also holds intellectual property related to treatments for rheumatoid arthritis, osteoarthritis, and psoriasis. Separately, under the name "ARC Pharma (UK) Ltd", the company provides GMP-certified contract laboratory services including advanced R&D research projects and routine quality testing for pharmaceutical clients.[1][5]
- Therapeutic areas
- OtherDermatologyRheumatologyImmunology
- Industry
- Biotech
Beyond the preview
Go deeper on ARC PHARMA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ARC PHARMA.